Show simple item record

dc.contributor.authorTaylor, EL
dc.contributor.authorArmstrong, KR
dc.contributor.authorPerrett, D
dc.contributor.authorHattersley, Andrew T.
dc.contributor.authorWinyard, PG
dc.date.accessioned2015-08-19T12:10:45Z
dc.date.issued2015-04-14
dc.description.abstractAdvanced oxidation protein products (AOPP) are reportedly elevated in the plasma of patients with a number of diseases, including diabetes mellitus, that involve oxidative stress. However, the accurate measurement of AOPP in human plasma is hampered by the formation of a precipitate following the addition of potassium iodide and glacial acetic acid according to the published assay procedure. Here we describe a modification of the AOPP assay which eliminates interference by precipitation and provides a robust, reliable, and reproducible protocol for the measurement of iodide oxidising capacity in plasma samples (intra-assay CV 1.7-5.3%, interassay CV 5.3-10.5%). The improved method revealed a significant association of AOPP levels with age (p < 0.05) and hypertension (p = 0.01) in EDTA-anticoagulated plasma samples from 52 patients with diabetes and 38 nondiabetic control subjects, suggesting a possible link between plasma oxidising capacity and endothelial and/or vascular dysfunction. There was no significant difference between AOPP concentrations in diabetic (74.8 ± 7.2 μM chloramine T equivalents) and nondiabetic (75.5 ± 7.0 μM chloramine T equivalents) individuals.en_GB
dc.description.sponsorshipBBSRCen_GB
dc.description.sponsorshipEPSRCen_GB
dc.description.sponsorshipNIHR Exeter Clinical Research Facilityen_GB
dc.identifier.citationVol. 2015, pp. 496271 -en_GB
dc.identifier.doi10.1155/2015/496271
dc.identifier.urihttp://hdl.handle.net/10871/18079
dc.language.isoenen_GB
dc.publisherHindawi Publishing Corporationen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/26113954en_GB
dc.relation.urlhttp://www.hindawi.com/journals/omcl/2015/496271/en_GB
dc.rightsThis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Available at http://www.hindawi.com/journals/omcl/2015/496271/en_GB
dc.titleOptimisation of an Advanced Oxidation Protein Products Assay: Its Application to Studies of Oxidative Stress in Diabetes Mellitusen_GB
dc.typeArticleen_GB
dc.date.available2015-08-19T12:10:45Z
dc.identifier.issn1942-0900
dc.relation.isreplacedby10871/25913
dc.relation.isreplacedbyhttp://hdl.handle.net/10871/25913
exeter.place-of-publicationUnited States
dc.descriptionJournal Articleen_GB
dc.descriptionCopyright © 2015 Emma L. Taylor et al.en_GB
dc.descriptionThis is the post print version of an Open Access article available at http://www.hindawi.com/journals/omcl/2015/496271/.en_GB
dc.identifier.journalOxidative Medicine and Cellular Longevityen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record